Anagnostics develops multiplex clinical diagnostics. We provide solutions for unmet clinical needs especially in the fields of integrated sepsis diagnostics, companion diagnostics and drugs of abuse screening.
Anagnostics Bioanalysis GmbH was founded in 2006 and is located in St. Valentin, Austria. We focus on the development, production and distribution of multiplex tests for routine use in clinical laboratories. Our team comprises of specialists in molecular diagnostics, mechatronics and software engineering. Our focus for development is user-friendliness of our products.
Multiplex diagnostics provide parallel evidence of a number of different characteristics (bacteria, gene mutations, drugs of abuse, etc.) in a single test, requiring only minimal amount of sample.
Our vision is to establish our proprietary multiplex diagnostics technology - hybcell technology - as an internationally widely accepted standard for fast and comprehensive diagnostics for a number of applications.
hybcell - the world's unique cylindrical microarray - delivers speedy and reliable results at minimal effort. The hyborg - the completely automatic device - carries out the processing of the protocol without any intervention by the user.
Our aim is to provide solutions for unmet needs especially in the fields of drugs of abuse screening, severe infections and diagnostics in the field of oncology. We are convinced that our products contribute to an advancement of modern medicine and thus in the well-being of patients.